Rezulin
On March 21, 2000 the head of the FDA's Center for Drug Evaluation and Research (CDER) stated that "continued use of Rezulin posed an unacceptable risk to diabetes patients." This was not first time the drug's dangers were called into question. In 1996, during the FDA approval stage, the lead medical officer cited Rezulin as potentially harming to the liver and the heart. The drug, however, was approved in January 1997. By fall of 1997, dozens of patients on Rezulin were hospitalized and cases of hepatocellular cancer, ...MORE >>
Featured Articles on Rezulin
- July 2, 2004 - Pfizer to settle Illinois Rezulin suit
- July 8, 2003 - High Court Approves Class-Action Status for Rezulin Lawsuits
- September 13, 2002 - 4,000 Plaintiffs Denied Class Action Status in Rezulin Case
- May 2, 2002 - Pfizer Hit With $11.55 Million Rezulin Verdict
- December 18, 2001 - Drug Maker's Victory May Change Tactics
- December 18, 2001 - Drug Company Wins First Jury Trial Over Rezulin
- August 14, 2001 - FDA increases efforts to avert drug-induced liver damage
- July 31, 2001 - Four file suit over Rezulin drugs claims
- March 12, 2001 - Company knew liver-damage risk of drug, documents suggest a government medical officer's critical memorandum was stifled.
- June 1, 1999 - Woman files product liability suit against Rezulin manufacturer
- April 15, 1999 - Rezulin target of lawsuit by liver failure victim
Browse Books About Drug Litigation
The above is not legal advice. That can only come from a qualified attorney who is familiar with all the facts and circumstances of a particular, specific case and the relevant law. See Terms of Use.
